A class action lawsuit has been filed against Park Ha Biological Technology, accusing the company and some executives of securities fraud through a pump-and-dump scheme. The complaint claims Park Ha's stock price was artificially inflated from $4.00 at IPO to $41.49 via fraudulent promotions and impersonation of financial advisors on social media. This manipulation led to a market collapse, harming investors. The case is open for investors to join as Lead Plaintiff until September 28, 2026.
Park Ha Biological Technology lawsuit news is presented with Pluang's health sector data for context. For readers following health stocks, 59 of 91 US health-sector stocks rose and 31 fell today. Notable movers include NVAX at USD 10.17 with +8.77% change and 100% buy order activity, TXG at USD 78.51 with +8.02% change and balanced buy/sell activity, and SANA at USD 3.12 with +6.85% change and 86% sell order activity, as of Sep 17, 2026 21:11 WIB.
Aerie, developed by LayerZero Labs and partners, aggregates 32,768 post-quantum signatures in just 0.65 seconds using a MacBook Pro without specialized hardware. It outperforms previous systems by generating and verifying proofs faster and producing ...
Bitcoin has experienced a 25% decline over the past year but continues to show long-term momentum, according to Charles Schwab analyst Adam Lynch. Despite this pullback, cumulative net inflows into U.S. spot Bitcoin ETFs have reached nearly $57 billi...
Digital-asset treasury companies collectively hold an estimated 1.073 million Bitcoin (BTC), with Strategy holding the largest share at 848,500 BTC. This estimate slightly exceeds Strategy's last disclosed balance by 250 BTC, reflecting recent purcha...
Zcash (ZEC) experienced a sharp price decline of 4.62% within four hours, falling from $1,228 to $1,171 on October 16. This drop was significantly steeper than the 1.48% decrease observed over the past 24 hours, indicating increased short-term sellin...
Venice Token (VVV) rose 10% in 24 hours after successfully bouncing off the $21 support level, which was previously a resistance barrier. This surge follows the launch of new AI-powered products and strong revenue growth, especially in October. The $...
